Search

everythinglearnresearchcommunity

for

Search:↓

Prolactin may affect hair growth differently based on gender and scalp area.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Minoxidil effectively treats female pattern hair loss.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Stress and alcohol affect brain chemicals differently in rats, mice, and humans, influenced by genetic differences.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

Measuring reproductive hormones in brown bear hair could help identify their sex and reproductive state, but better collection methods or lab techniques are needed.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Early onset hair loss linked to genetics and androgen levels.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

Activating NRF2 might help treat hair disorders by improving antioxidant defenses.

Hair loss in women links to inflammation around hair follicles.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Researchers found genes that control hair color and growth change before the visible coat color changes in snowshoe hares.

Dogs could be good models for studying human hair growth and hair loss.

Adults with certain skin conditions may have higher levels of inflammation in their body.